Literature DB >> 10928209

First injection and current risk factors for HIV among new and long-term injection drug users.

D D Chitwood1, J Sanchez, M Comerford, J B Page, D C McBride, K R Kitner.   

Abstract

The purpose of this paper is to estimate HIV seroprevalence and to examine the injection and sexual risk behaviours of a cohort of active new heroin injectors who have initiated injection within the past four years and to compare their risk behaviours with those of long-term heroin injectors who initiated injection prior to January 1, 1985. A stratified network-based sample was used to recruit injection drug users (IDUs) from the streets of Miami-Dade, Florida. New IDUs displayed a significantly lower HIV seroprevalence than long-term injectors (13.3 versus 24.7%). Both new and long-term drug injectors exhibited a high level of current HIV risk behaviour. While new injectors were more likely than long-term injectors to practise safer injection behaviours at the initial injection episode, the current risk behaviours of new and long-term injectors are similar.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928209     DOI: 10.1080/09540120050042972

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  17 in total

1.  Injection drug use among stimulant users in a national sample.

Authors:  Li-Tzy Wu; Daniel J Pilowsky; Wendee M Wechsberg; William E Schlenger
Journal:  Am J Drug Alcohol Abuse       Date:  2004       Impact factor: 3.829

2.  Male injection drug users try new drugs following U.S. deportation to Tijuana, Mexico.

Authors:  Angela M Robertson; M Gudelia Rangel; Remedios Lozada; Alicia Vera; Victoria D Ojeda
Journal:  Drug Alcohol Depend       Date:  2011-08-10       Impact factor: 4.492

3.  First injection of ketamine among young injection drug users (IDUs) in three U.S. cities.

Authors:  Stephen E Lankenau; Bill Sanders; Jennifer Jackson Bloom; Dodi Hathazi; Erica Alarcon; Stephanie Tortu; Michael C Clatts
Journal:  Drug Alcohol Depend       Date:  2006-09-18       Impact factor: 4.492

4.  HIV among injection drug users in large US metropolitan areas, 1998.

Authors:  Samuel R Friedman; Spencer Lieb; Barbara Tempalski; Hannah Cooper; Marie Keem; Risa Friedman; Peter L Flom
Journal:  J Urban Health       Date:  2005-07-13       Impact factor: 3.671

5.  Factors related to correctional facility incarceration among active injection drug users in Baltimore, MD.

Authors:  Stevan Geoffrey Severtson; William W Latimer
Journal:  Drug Alcohol Depend       Date:  2007-12-21       Impact factor: 4.492

6.  Potential risk factors for injecting among Mexican American non-injecting heroin users.

Authors:  Avelardo Valdez; Alan Neaigus; Alice Cepeda
Journal:  J Ethn Subst Abuse       Date:  2007       Impact factor: 1.507

7.  Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014.

Authors:  Huong Thi Duong; Don Des Jarlais; Oanh Hai Thi Khuat; Kamyar Arasteh; Jonathan Feelemyer; Pham Minh Khue; Hoang Thi Giang; Didier Laureillard; Vinh Vu Hai; Roselyne Vallo; Laurent Michel; Jean Pierre Moles; Nicolas Nagot
Journal:  AIDS Behav       Date:  2018-07

8.  Risk factors associated with the transition from heroin sniffing to heroin injection: a street addict role perspective.

Authors:  Jesús Sánchez; Dale D Chitwood; Dixie J Koo
Journal:  J Urban Health       Date:  2006-09       Impact factor: 3.671

9.  Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.

Authors:  Keri L Calkins; Catherine R Lesko; Geetanjali Chander; Richard D Moore; Bryan Lau
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

10.  An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men.

Authors:  Spencer Lieb; Samuel R Friedman; Mary Beth Zeni; Dale D Chitwood; Thomas M Liberti; Gary J Gates; Lisa R Metsch; Lorene M Maddox; Tamara Kuper
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.